BHIVA & EACS release updated statement on COVID-19 & HIV
On Monday, May 25, the British HIV Association (BHIVA), in collaboration with the European AIDS Clinical Society (EACS), DAIG, GESIDA and the Polish AIDS Science Society, released an updated statement on the risks of COVID-19 coronavirus infection for people living with HIV (PLHIV).
Data on a series of cases of COVID-19 in HIV patients have been published in China, Spain, Germany, Italy and the USA. However, to date, there is still no clear evidence that suggests that PLHIV have a higher risk of becoming infected by SARS-CoV-2 or a different course of COVID-19 disease.
18 mai 2020 13:03
Every two-month injections show higher efficacy than oral PrEP
Today, Monday 18th May 2020, the HIV Prevention Trials Network (HPTN) announced the interim analysis of their study HPTN 083 which was evaluating the efficacy and safety of long-acting injectable cabotegravir for the prevention of HIV.
In the study cabotegravir ...
Lugege edasi
15 mai 2020 10:49
Gilead agrees licenses for generic manufacturing of Remdesivir
Gilead Science, the American biotech company behind the antiviral agent Remdesivir has entered into a non-exclusive licensing agreement with five generic manufacturers from India and Pakistan to produce and market the drug, which has the potential for antiviral ...
Lugege edasi
Mis on Life4me+?
Üks Life4me+ peamiseid eesmärke on uute HIVi- ja muude sugulisel teel levivate nakkuste juhtumite, nagu ka C-hepatiiti ja tuberkuloosi nakatumise ennetamine. Seepärast räägime HIVist ja muudest haigustest — sellest, kuidas end nende eest kaitsta ja kuidas elada nakatununa.
Rohkem
Kampaania Life4me+
Info haridusliku kampaania "M = M" kohta ("Mittetuvastatav = mitteedasikanduv", #UequalsU, #НравноН), mis on Life4me+ poolt organiseeritud Ida-Euroopas ja Kesk-Aasias regioonis, suunatud info levitamisele, et HIV-positiivne inimene mittetuvastatava viiruskoormusega ei saa viirust seksuaalsel teel edasi kanda teisele inimesele.
Mitmed uuringud on näidanud, et diskordantses paaris, kus HIV-positiive partner võtab ARV ravimeid ja hoiab viiruskoormuse mittetuvastataval tasemel, ei ole teada juhtumitest, kus HIV oleks seksuaalsel teel edasi kandunud.
Meie partnerid
